- Report
- April 2025
- 50 Pages
Global
From €2486EUR$2,650USD£2,137GBP
Rufloxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to the fluoroquinolone class of antibiotics, which are used to treat a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. Rufloxacin is effective against both gram-positive and gram-negative bacteria, making it a useful tool in the treatment of many bacterial infections. It is also used to treat some sexually transmitted diseases, such as gonorrhea.
Rufloxacin is available in both oral and intravenous forms, and is generally well tolerated by patients. Common side effects include nausea, vomiting, and diarrhea. Rare side effects include tendon rupture and liver damage.
The market for rufloxacin is highly competitive, with many pharmaceutical companies producing generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Show Less Read more